CANCER MANAG RES 润色咨询

Cancer Management and Research

出版年份:暂无数据 年文章数:4148 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:5.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=849f13107, cover=https://img.medsci.cn/images/journal/cover/2021/vLl_202109271314377310.jpg, fullname=Cancer Management and Research, abbr=CANCER MANAG RES, pyear=暂无数据, frequence=Irregular, articleNumbers=4148, citedSelf2015=5.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2月, reviewFee=null, pageFee=2541.67, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1179-1322, greenSci=https://www.greensci.net/search?kw=1179-1322, scijournal=https://www.scijournal.org/impact-factor-of-CANCER-MANAG-RES.shtml, medsciHotlightString=null, medsciHotlightRealtime=23.236, medsciHotlight=46.227, medsciHotlight5year=56.6799, citescore=7.4, hIndex=40, impactFactor=3.3, orgnization=Dove Medical Press Ltd., orgnizationUrl=https://www.dovepress.com, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Scopus|Science Citation Index Expanded, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://www.dovepress.com/cancer-management-and-research-journal, websiteHits=21066, guideForAuthor=https://www.dovepress.com/author_guidelines.php, guideForAuthorHits=2924, submitWebsite=https://www.dovepress.com/submit_step_1.php, submitWebsiteHits=18323, content=<p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;"><em style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 13.125px; vertical-align: baseline; background: transparent; user-select: text !important;">Cancer Management and Research</em> is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;"> </p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Epidemiology, detection and screening</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Cellular research and biomarkers</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Identification of biotargets and agents with novel mechanisms of action</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Optimal clinical use of existing anticancer agents, including combination therapies</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Radiation and surgery</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Palliative care</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Patient adherence, quality of life, satisfaction</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">◦Health economic evaluations</p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;"> </p> <p style="margin: 0px 0px 0.6875em; padding: 0px; border: 0px; outline: 0px; font-size: 0.875em; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: Verdana,;">The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype. The journal does not consider case reports except in exceptional circumstances.</p>, totalCites=13689, brief=CANCER MANAG RES杂志医学行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #0000ff;">蓝</span>, medsciComment=虽然从国际上看,影响力一般。另外,大家关注整体偏低了一些,但是这是中国本土SCI期刊,取得这样成绩也是相当不错的,希望大家多关注支持!, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=849f13107'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=26), ImpactFactorTagDto(id=11469, tagName=肿瘤标记物, createdHits=6), ImpactFactorTagDto(id=111501, tagName= 肿瘤 , createdHits=4), ImpactFactorTagDto(id=803, tagName=Cancer, createdHits=3), ImpactFactorTagDto(id=111535, tagName= 肝癌 , createdHits=2), ImpactFactorTagDto(id=41103, tagName=分子生物, createdHits=2), ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=2), ImpactFactorTagDto(id=428, tagName=肺癌, createdHits=2), ImpactFactorTagDto(id=804, tagName=放疗, createdHits=2), ImpactFactorTagDto(id=2030, tagName=肝纤维化, createdHits=1), ImpactFactorTagDto(id=412, tagName=淋巴瘤, createdHits=1), ImpactFactorTagDto(id=1246, tagName=免疫治疗, createdHits=1), ImpactFactorTagDto(id=113148, tagName= 综述 , createdHits=1), ImpactFactorTagDto(id=2992, tagName=慢病管理, createdHits=1), ImpactFactorTagDto(id=112998, tagName= 胰腺肿瘤手术 , createdHits=1), ImpactFactorTagDto(id=111631, tagName= 肿瘤 , createdHits=1), ImpactFactorTagDto(id=111746, tagName= 肿瘤治疗 , createdHits=1), ImpactFactorTagDto(id=109469, tagName=肿瘤康复, createdHits=1), ImpactFactorTagDto(id=111533, tagName= 肿瘤标记物 , createdHits=1), ImpactFactorTagDto(id=81423, tagName=肿瘤免疫微环境, createdHits=1), ImpactFactorTagDto(id=41156, tagName=肿瘤基础研究, createdHits=1), ImpactFactorTagDto(id=8392, tagName=Oncology, createdHits=1), ImpactFactorTagDto(id=438, tagName=胃癌, createdHits=1), ImpactFactorTagDto(id=66088, tagName=胰腺肿瘤手术, createdHits=1), ImpactFactorTagDto(id=13403, tagName=lncRNA, createdHits=1), ImpactFactorTagDto(id=429, tagName=肝癌, createdHits=1), ImpactFactorTagDto(id=3184, tagName=综述, createdHits=1), ImpactFactorTagDto(id=6352, tagName=基础研究, createdHits=1), ImpactFactorTagDto(id=3941, tagName=肿瘤治疗, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.32), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.42), GetImpactFactorCiteScoreListResponse(year=2019, citescore=1.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=3.3), GetImpactFactorCiteScoreListResponse(year=2023, citescore=7.4)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=62.505), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=97.54), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=35.607), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=41.844), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=23.236)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Oncology , rank=239/331)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY - SCIE , rank=145/244)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1179-1322[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Cancer Management and Research[ta], article_number=319, article_number_cn=173, earlyWarning=中科院预警:中(2021);吉大一院预警, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CANCER MANAG RES/Cancer Management and Research
ISSN
1179-1322
影响指数话题
预警等级
中科院预警:中(2021);吉大一院预警
MedSci期刊指数
23.236 (MedSci实时期刊指数) | 56.6799 (5年期刊指数)
CiteScore值
7.4
h-index
40
h5-median
暂无数据
出版社/管理机构
杂志由 Dove Medical Press Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Irregular
出版年份
暂无数据
是否OA
被收录情况
Scopus|Science Citation Index Expanded
JCR分区
ONCOLOGY - SCIE 145/244
中科院分区
大类:医学 3区
小类:医学 3 区